Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Ramelteon

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aurobindo's Generic Ramelteon Receives Approval in the U.S.
    Aurobindo's Generic Ramelteon Receives Approval in the U.S.

    10 Jul 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215972

    FDA
    10 Jul 2023
    Share Share
    Xiromed's Generic Ramelteon Receives Approval in the U.S.
    Xiromed's Generic Ramelteon Receives Approval in the U.S.

    25 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216209

    FDA
    25 Nov 2022
    Share Share
    Enaltec's Generic Ramelteon Receives Approval in the U.S.
    Enaltec's Generic Ramelteon Receives Approval in the U.S.

    24 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215435

    FDA
    24 Aug 2022
    Share Share
    Granules' subsidiary bags USFDA approval for Ramelteon tablet
    Granules' subsidiary bags USFDA approval for Ramelteon tablet

    24 Aug 2020

    // INDIAINFOLINE

    https://www.indiainfoline.com/article/news-sector-pharma-healthcare/granules-subsidiary-bags-usfda-approval-for-ramelteon-tablet-120082400368_1.html

    INDIAINFOLINE
    24 Aug 2020
    Share Share
    Granules Pharma's Generic Ramelteon Receives Approval In US
    Granules Pharma's Generic Ramelteon Receives Approval In US

    21 Aug 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213186

    FDA
    21 Aug 2020
    Share Share
    Zydus Cadila launches insomnia drug in US market
    Zydus Cadila launches insomnia drug in US market

    25 Jul 2019

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-launches-insomnia-drug-in-us-market/articleshow/70358246.cms

    ECONOMIC TIMES
    25 Jul 2019
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.